Literature DB >> 11480304

A rare case of renal cell carcinoma metastatic to the sinonasal area.

L L Yee1, C G Keng.   

Abstract

We report a rare case of a hypernephroma that had metastasized to the sinonasal area as a solitary mass. Despite much difficulty, a confirmatory biopsy of the nasal mass was obtained. After radiotherapy had failed to arrest the tumor's growth, the mass was removed via a craniofacial resection. This case illustrates the importance of (1) a high index of suspicion in differentiating this rare tumor from other benign or malignant diseases, (2) awareness of the risk of hemorrhage and the role of preoperative embolization, (3) the need for paraffin histology rather than fine-needle aspiration or frozen section diagnosis, (4) individualizing therapy after due consideration of the characteristics of both the patient and the tumor, and (5) keeping abreast of the most current therapeutic modalities so that patient management can be individualized and optimized. Surgical excision offers the best hope for long-term survival, and it reduces the degree of pain, epistaxis, and disfigurement from the expanding tumor. When such tumors are not resectable, management with radiotherapy, hormonal therapy, immunotherapy, or chemotherapy can be considered.

Entities:  

Mesh:

Year:  2001        PMID: 11480304

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  3 in total

1.  Renal cell carcinoma metastasis to the paranasal sinuses and orbit.

Authors:  Evgenios Evgeniou; Kavitha R Menon; Graeme L Jones; Heiki Whittet; Wynne Williams
Journal:  BMJ Case Rep       Date:  2012-03-27

2.  Sinonasal renal cell-like adenocarcinoma: a report on four patients.

Authors:  K Storck; U Moh'd Hadi; R Simpson; M Ramer; M Brandwein-Gensler
Journal:  Head Neck Pathol       Date:  2008-04-22

3.  Renal cell carcinoma metastatic to the nasal cavity.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2012-07-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.